Triple
T426277
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | National Heart, Lung, and Blood Institute |
E9613
|
entity |
| Predicate | hasPart |
P35
|
FINISHED |
| Object |
Division of Blood Diseases and Resources
The Division of Blood Diseases and Resources is a branch of the National Heart, Lung, and Blood Institute that supports research, training, and resources related to blood disorders and transfusion medicine.
|
E9613
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Division of Blood Diseases and Resources | Statement: [National Heart, Lung, and Blood Institute, hasPart, Division of Blood Diseases and Resources]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Division of Blood Diseases and Resources Context triple: [National Heart, Lung, and Blood Institute, hasPart, Division of Blood Diseases and Resources]
-
A.
NHS Blood and Transplant
NHS Blood and Transplant is a UK special health authority responsible for providing a safe and reliable supply of blood, organs, and associated services to the National Health Service.
-
B.
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
C.
National Heart, Lung, and Blood Institute
The National Heart, Lung, and Blood Institute is a U.S. government biomedical research institute that leads and funds research, training, and education focused on heart, lung, blood, and sleep disorders.
-
D.
Division of Cancer Treatment and Diagnosis
The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.
-
E.
National Institute of Diabetes and Digestive and Kidney Diseases
The National Institute of Diabetes and Digestive and Kidney Diseases is a U.S. government biomedical research institute that conducts and supports research on diabetes, digestive disorders, kidney diseases, and related metabolic and endocrine conditions.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Division of Blood Diseases and Resources Triple: [National Heart, Lung, and Blood Institute, hasPart, Division of Blood Diseases and Resources]
Generated description
The Division of Blood Diseases and Resources is a branch of the National Heart, Lung, and Blood Institute that supports research, training, and resources related to blood disorders and transfusion medicine.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Division of Blood Diseases and Resources Target entity description: The Division of Blood Diseases and Resources is a branch of the National Heart, Lung, and Blood Institute that supports research, training, and resources related to blood disorders and transfusion medicine.
-
A.
NHS Blood and Transplant
NHS Blood and Transplant is a UK special health authority responsible for providing a safe and reliable supply of blood, organs, and associated services to the National Health Service.
-
B.
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
C.
National Heart, Lung, and Blood Institute
chosen
The National Heart, Lung, and Blood Institute is a U.S. government biomedical research institute that leads and funds research, training, and education focused on heart, lung, blood, and sleep disorders.
-
D.
Division of Cancer Treatment and Diagnosis
The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.
-
E.
National Institute of Diabetes and Digestive and Kidney Diseases
The National Institute of Diabetes and Digestive and Kidney Diseases is a U.S. government biomedical research institute that conducts and supports research on diabetes, digestive disorders, kidney diseases, and related metabolic and endocrine conditions.
- F. None of above.
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a2e801e1d48190b505d1dd336b52ac |
completed | Feb. 28, 2026, 1:05 p.m. |
| NER | Named-entity recognition | batch_69a2eed691c4819092b7e57306114bbc |
completed | Feb. 28, 2026, 1:34 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a42a187e208190ba58c0d9f68aaef8 |
completed | March 1, 2026, 11:59 a.m. |
| NEDg | Description generation | batch_69a42a8b49b88190864aa55f49916a87 |
completed | March 1, 2026, 12:01 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69a42b030ccc819086ae0c96ca1ba4a8 |
completed | March 1, 2026, 12:03 p.m. |
Created at: Feb. 28, 2026, 1:11 p.m.